| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |